Scholars Central

Research articlePublished 3 May 2019

PREVENTIVE MEASURES NEEDED FOR LONG TERM USE OF CARBAMAZEPINE TO LOWER THE RISK FOR CORONARY HEART DISEASE

Authors: Paunipagar Prashant V, Babu Ramesh B, Sharma Rahul P

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Present cross sectional study was carried out with a view to evaluate the Carbamazepine risk for coronary heart disease. Lipid profile and Framingham point scores were studied in 60 Epilepsy patients on Carbamazepine. The epileptic patients were compared with age and sex matched 60 healthy controls. Framingham Point Scores were estimated by taking into consideration several parameters i.e. Age, Sex, Systolic blood pressure, HDL levels, Total cholesterol, and smoking history, as per guidelines of the Framingham Heart Study group We conclude that this drug significantly increases the risk for coronary heart disease in patients with respect to lipid profile and other parameters as described by the Framingham study group. Altogether, this drug may be one of the reasons for the high prevalence of CHD, which is increasing day-by-day due to the globalization.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInternational Journal of Medical Research & Health Sciences
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Paunipagar Prashant V”
  • BylineArticles whose byline prints “Babu Ramesh B”
  • BylineArticles whose byline prints “Sharma Rahul P”